FindTrial
Sign In

6 months DAPT

DRUG3 trials

Sponsors

Maasstad Hospital, Ajou University School of Medicine, Shanghai MicroPort Medical (Group) Co., Ltd.

Conditions

Cardiovascular DiseaseCoronary DiseaseDrug Eluting StentDual Antiplatelet TherapyMyocardial InfarctionPercutaneous Coronary InterventionStable Angina, Unstable Angina, Silent Coronary Ischemia, Coronary Artery Disease

Phase 4

Randomized, Open Label Trial of 6 Months Versus 12 Months DAPT After Drug-Eluting Stent in STEMI
CompletedNCT01459627
Maasstad HospitalCardiovascular Disease, Myocardial Infarction
Start: 2011-12-31End: 2017-08-31Target: 1100Updated: 2017-09-07
ISAR-DAPT (A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial)
NCT02609698
Ajou University School of MedicineStable Angina, Unstable Angina, Silent Coronary Ischemia, Coronary Artery Disease
Start: 2015-08-31End: 2019-06-30Target: 906Updated: 2015-11-20
Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease
NCT03287167
Shanghai MicroPort Medical (Group) Co., Ltd.Coronary Disease, Drug Eluting Stent, Dual Antiplatelet Therapy +1
Start: 2019-06-01End: 2023-07-30Target: 1720Updated: 2020-09-09

Related Papers

Defining the HBR patient – another step in the right direction
EuroIntervention2020-08-012 citations
Resolute zotarolimus‐eluting stent in ST‐elevation myocardial infarction (resolute‐STEMI): A prespecified prospective register from the DAPT‐STEMI trial
Catheterization and Cardiovascular Interventions2019-07-032 citations
Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial
BMJ2018-10-02177 citations